BACKGROUND & AIMS: Bile diversion to the ileum (GB-IL) has strikingly similar metabolic and satiating effects to Roux-en-Y gastric bypass (RYGB) in rodent obesity models. The metabolic benefits of these procedures are thought to be mediated by increased bile acids, although parallel changes in body weight and other confounding variables limit this interpretation. METHODS: Global G protein-coupled bile acid receptor-1 null (Tgr5-/-) and intestinal-specific farnesoid X receptor null (FxrΔ/E) mice on high-fat diet as well as wild-type C57BL/6 and glucagon-like polypeptide 1 receptor deficient (Glp-1r-/-) mice on chow diet were characterized following GB-IL. RESULTS: GB-IL induced weight loss and improved oral glucose tolerance in Tgr5-/-, but not FxrΔ/E mice fed a high-fat diet, suggesting a role for intestinal Fxr. GB-IL in wild-type, chow-fed mice prompted weight-independent improvements in glycemia and glucose tolerance secondary to augmented insulin responsiveness. Improvements were concomitant with increased levels of lymphatic GLP-1 in the fasted state and increased levels of intestinal Akkermansia muciniphila. Improvements in fasting glycemia after GB-IL were mitigated with exendin-9, a GLP-1 receptor antagonist, or cholestyramine, a bile acid sequestrant. The glucoregulatory effects of GB-IL were lost in whole-body Glp-1r-/- mice. CONCLUSIONS: Bile diversion to the ileum improves glucose homeostasis via an intestinal Fxr-Glp-1 axis. Altered intestinal bile acid availability, independent of weight loss, and intestinal Akkermansia muciniphila appear to mediate the metabolic changes observed after bariatric surgery and might be manipulated for treatment of obesity and diabetes.
BACKGROUND & AIMS: Bile diversion to the ileum (GB-IL) has strikingly similar metabolic and satiating effects to Roux-en-Y gastric bypass (RYGB) in rodent obesity models. The metabolic benefits of these procedures are thought to be mediated by increased bile acids, although parallel changes in body weight and other confounding variables limit this interpretation. METHODS: Global G protein-coupled bile acid receptor-1 null (Tgr5-/-) and intestinal-specific farnesoid X receptor null (FxrΔ/E) mice on high-fat diet as well as wild-type C57BL/6 and glucagon-like polypeptide 1 receptor deficient (Glp-1r-/-) mice on chow diet were characterized following GB-IL. RESULTS:GB-IL induced weight loss and improved oral glucose tolerance in Tgr5-/-, but not FxrΔ/E mice fed a high-fat diet, suggesting a role for intestinal Fxr. GB-IL in wild-type, chow-fed mice prompted weight-independent improvements in glycemia and glucose tolerance secondary to augmented insulin responsiveness. Improvements were concomitant with increased levels of lymphatic GLP-1 in the fasted state and increased levels of intestinal Akkermansia muciniphila. Improvements in fasting glycemia after GB-IL were mitigated with exendin-9, a GLP-1 receptor antagonist, or cholestyramine, a bile acid sequestrant. The glucoregulatory effects of GB-IL were lost in whole-body Glp-1r-/- mice. CONCLUSIONS: Bile diversion to the ileum improves glucose homeostasis via an intestinal Fxr-Glp-1 axis. Altered intestinal bile acid availability, independent of weight loss, and intestinal Akkermansia muciniphila appear to mediate the metabolic changes observed after bariatric surgery and might be manipulated for treatment of obesity and diabetes.
Authors: Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Ali Aminian; Stacy A Brethauer; Sankar D Navaneethan; Rishi P Singh; Claire E Pothier; Steven E Nissen; Sangeeta R Kashyap Journal: N Engl J Med Date: 2017-02-16 Impact factor: 91.245
Authors: Bryan J Sandler; Roberto Rumbaut; C Paul Swain; Gustavo Torres; Luis Morales; Lizcelly Gonzales; Sarah Schultz; Mark A Talamini; Garth R Jacobsen; Santiago Horgan Journal: Surg Endosc Date: 2015-01-29 Impact factor: 4.584
Authors: Amandine Everard; Clara Belzer; Lucie Geurts; Janneke P Ouwerkerk; Céline Druart; Laure B Bindels; Yves Guiot; Muriel Derrien; Giulio G Muccioli; Nathalie M Delzenne; Willem M de Vos; Patrice D Cani Journal: Proc Natl Acad Sci U S A Date: 2013-05-13 Impact factor: 11.205
Authors: Brian E Kadera; Kristian Lum; John Grant; Aurora D Pryor; Dana D Portenier; Eric J DeMaria Journal: Surg Obes Relat Dis Date: 2009-02-26 Impact factor: 4.734
Authors: Igal Breitman; James M Isbell; Jabbar Saliba; Kareem Jabbour; Charles Robb Flynn; Pamela A Marks-Shulman; Blandine Laferrère; Naji N Abumrad; Robyn A Tamboli Journal: Diabetes Care Date: 2013-04 Impact factor: 19.112
Authors: Eric D Berglund; Candice Y Li; Greg Poffenberger; Julio E Ayala; Patrick T Fueger; Shannon E Willis; Marybeth M Jewell; Alvin C Powers; David H Wasserman Journal: Diabetes Date: 2008-04-08 Impact factor: 9.461
Authors: Mohammed K Hankir; Michael Rullmann; Florian Seyfried; Sven Preusser; Sindy Poppitz; Stefanie Heba; Konstantinos Gousias; Jana Hoyer; Tatjana Schütz; Arne Dietrich; Karsten Müller; Burkhard Pleger Journal: JCI Insight Date: 2019-10-03
Authors: Robyn M Brown; Eva Guerrero-Hreins; Wendy A Brown; Carel W le Roux; Priya Sumithran Journal: Nat Rev Endocrinol Date: 2021-07-14 Impact factor: 43.330